Gonococci and Meningococci

Epidemiology and vaccination

1. Front Matter

   Pages 1-1

   PDF

2. Epidemiology and vaccination

   • H. C. Zanen

   Pages 3-4

3. Class 1OMP subtyping of meningococci

   • H. Abdillahi, J. T. Poolman

   Pages 5-10

4. The reduction of nitrite by Neisseria meningitidis. Relation to serogroup and serotype

   • F. E. Ashton, F. Collins, J. A. Ryan, B. B. Diena

   Pages 11-14

5. Monoclonal antibody analysis of meningococcal disease strains isolated in Canada

   • F. E. Ashton, J. A. Ryan, B. B. Diena, W. D. Zollinger

   Pages 15-19

6. Outcome of Neisseria meningitidis serogroup C infection in a small outbreak of disease

   • G. Bjune, P. Brandtzæg, L. F. Engebretsen, K. J. Figenschau, L. O. Frøholm, P. Gaustad et al.

   Pages 21-25

7. Epidemiology of meningococcal (sub)types in the Netherlands

   • P. Bol, L. Spanjaard, C. Hopman, A. Arends, F. Kersten, H. C. Zanen

   Pages 27-32

8. Tetravalent meningococcal polysaccharide vaccine. Relationship of dose to immunogenicity and reactogenicity in young adults

   • B. L. Brandt, J. McLeod Griffiss, D. D. Broud, J. W. Boslego

   Pages 33-37

9. Plasma LPS and clinical pictures in meningococcal disease

   • P. Brandtzaeg, P. Kierulf, L. F. Engebretsen, P. Gaustad

   Pages 39-43

10. Serological classification of Neisseria gonorrhoeae. Clinical and epidemiological applications

    • Eric Sandström, Solgun Bygdeman

    Pages 45-50

11. Epidemiology of meningococcal disease in Switzerland, 1980–1986:Using monoclonal antibodies to classify disease-related isolates

    • P. Calain, F. Fleury, E. Leemans, J. Poolman, W. Zollinger, G. Sperber et al.

    Pages 51-55

12. Intercontinental spread of Neisseria Meningitidis clones of the ET-5 Complex

    • D. A. Caugant, L. O. FrØHolm, K. BØVre, E. Holten, C. E. Frasch, L. F. Mocca et al.

    Pages 57-62

13. Serological Classification of Neisseria Gonorrhoeae. Serovars Associated with Homosexually Acquired Infection

    • D. V. Coghill, R. Gaitonde, G. Kelly, H. Young

    Pages 63-72

14. A clonal analysis of Neisseria meningitidis serogroup A

    • B. A. Crowe, T. Olyhoek, B. Neumann, B. Wall, M. Hassan-King, B. Greenwood et al.

    Pages 73-80

15. Epidemiology of Infections with Pathogenic Neisseriae in Sweden

    • D. Danielsson, P. OlcéN

    Pages 81-90

16. Immunoglobulin isotype deficiency and response to meningococcal polysaccharides

    • M. Elcock, J. McLEOD Griffiss, L. Å. Hanson, J. Björkander

    Pages 91-96

17. Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development

    • C. E. Frasch, L. F. Mocca, A. B. Karpas

    Pages 97-104

18. Monitoring of systemic meningococcal isolates from Norway

    • L. O. FrØHolm, E. Holten, E. A. HØIby, D. A. Caugant, W. D. Zollinger

    Pages 105-108

19. Immune response to meningococcal serogroup B polysaccharide and serotype 2a outer membrane complex vaccines

    • A. Halstensen, H. Sjursen, L. O. FrØHolm, E. A. HØIby, C. E. Frasch, W. D. Zollinger

    Pages 109-113